(Q56786008)

English

Effect of Pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients

scientific article published on 02 June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Effect of Pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Rituparna Maiti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

D Dash

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

B L Pandey

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

0 references

publication date

2 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

118-124

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Kinetics of intravenous and oral pentoxifylline in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

C-reactive Protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Is pentoxifylline the drug of the decade?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

In vitro synthesis of hemoglobin AIc

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

The fire that burns within: C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

C-reactive protein and glycemic control in adults with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Protein kinase C activation and the development of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Markers of inflammation and thrombosis: clues to plaque instability?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Pentoxyphylline and propentophylline are inhibitors of TNF-alpha release in monocytes activated by advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Evidence for a potent antiinflammatory effect of rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Inflammation in acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

A new colorimetric method for the estimation of glycosylated hemoglobin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Is type II diabetes mellitus a disease of the innate immune system?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

New Markers of Inflammation and Endothelial Cell Activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Biomarkers of vascular disease linking inflammation to endothelial activation: Part II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Association between acute-phase reactants and advanced glycation end products in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Inflammatory and thrombotic mechanisms in coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Pentoxifylline in management of proteinuria in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

C-reactive protein: structure affects function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

The metabolic syndrome: practical guide to origins and treatment: Part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Coming of age of C-reactive protein: using inflammation markers in cardiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.05.004

7 January 2021

Identifiers

10.1016/J.VPH.2007.05.004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613279%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56786008&oldid=2127251411"